The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Reporting owner

Calvin Sandra

Reporting owner CIK 0001882909 · SVP, CHIEF ACCOUNTING OFFICER

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Calvin SandraCalvin SandraCalvin Sandra · November 4, 2025 · Exercise / conversion · Common StockCalvin Sandra · November 4, 2025 · Exercise / conversion · Common StockCalvin Sandra · November 4, 2025 · Exercise / conversion · Common StockCalvin Sandra · November 4, 2025 · Exercise / conversion · Common StockCalvin Sandra · November 4, 2025 · Exercise / conversion · Common StockNov 4, 2025Nov 4, 2025
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

5 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Nov 4, 2025Travere Therapeutics, Inc.Common StockCalvin SandraExercise / conversion
Nov 4, 2025Travere Therapeutics, Inc.Common StockCalvin SandraExercise / conversion
Nov 4, 2025Travere Therapeutics, Inc.Common StockCalvin SandraExercise / conversion
Nov 4, 2025Travere Therapeutics, Inc.Common StockCalvin SandraExercise / conversion
Nov 4, 2025Travere Therapeutics, Inc.Common StockCalvin SandraExercise / conversion

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Travere Therapeutics, Inc.TVTX · company listings
Calvin SandraSVP, CHIEF ACCOUNTING OFFICER
Exercise / conversionCommon StockNon-derivative security · Code M6,2508.93Value: 55,812.5Currency not specifiedView ↗
Trade: Travere Therapeutics, Inc.TVTX · company listings
Calvin SandraSVP, CHIEF ACCOUNTING OFFICER
Exercise / conversionCommon StockNon-derivative security · Code M12,50022.4Value: 280,000Currency not specifiedView ↗
Trade: Travere Therapeutics, Inc.TVTX · company listings
Calvin SandraSVP, CHIEF ACCOUNTING OFFICER
Exercise / conversionCommon StockNon-derivative security · Code M15,00027.5Value: 412,500Currency not specifiedView ↗
Trade: Travere Therapeutics, Inc.TVTX · company listings
Calvin SandraSVP, CHIEF ACCOUNTING OFFICER
Exercise / conversionCommon StockNon-derivative security · Code M17,50026.88Value: 470,400Currency not specifiedView ↗
Trade: Travere Therapeutics, Inc.TVTX · company listings
Calvin SandraSVP, CHIEF ACCOUNTING OFFICER
Exercise / conversionCommon StockNon-derivative security · Code M10,00025.25Value: 252,500Currency not specifiedView ↗